Candidiasis and yeast infections;Candidoses et levuroses diverses

EMC - Maladies Infectieuses

Volumn 2, Issue 3, 2005, Pages 119-139

  Develoux, M ^a   Bretagne, S ^b  

^a HÔPITAL TENON   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Antifungal agents; Candidiasis; Cutaneo mucosal candidiasis; Disseminated candidiasis; Epidemiology

Indexed keywords

EID: 32644445920     PISSN: 1638623X     EISSN: 1638623X     Source Type: Journal    
DOI: 10.1016/j.emcmi.2005.04.001     Document Type: Short Survey

References (78)

1. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections In immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
2. van Burik JH, Leisenring W, Myerson D, Hackman RC, Shulman HM, Sale GE, et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients. Medicine 1998;77:246-54.
3. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbioi Infect Dis 2004;23:317-22.
4. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999;28:1071-9.
5. Stephan F, Bah MS, Desterke C, Rezaigula-Delclaux S, Foulet F, Duvaldestin P, et al. Molecular diversity and routes of colonization of Candida albicans In a surgical intensive care unit, as studied using microsatellite markers. Clin Infect Dis 2002;35:1477-83.
6. Pittet D. Candldémie et candldose généralisé e. Encycl Méd Chir (Elsevier SAS, Paris), Anesthésie, 36-983-D-10. 2000. 13p.
7. Soil DR. Candida commensalism and virulence: the evolution of phenotypic plasticity. Acta Trop 2002;81:101-10.
8. Hay RJ. The management of superficial candidiasls. J Am Acad Dermatol 1999;40:S35-42.
9. Pradeepkumar VK, Rajadurai VS, Tan KW. Congenital candidiasis: varied presentations. J Perinatol 1998;18: 311-6.
10. Rowen JL, Atkins JT, Levy ML, Baer SC, Baker CJ. Invasive fungal dermatitis In the < or = 1000-gram neonate. Pediatrics 1995;95:682-7.
11. Goettmann-Bonvallot S. Clinical types of onychomycosls. Ann Dermatol Venereal 2003;130:1237-43.
12. Vazquez JA, Sobel JD. Mucosal candidiasis. Infect Dis Clin North Am 2002;16:793-820.
13. Ohmit SE, Sobel JD, Schuman P, Duerr A, Mayer K, Rompalo A, et al. Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003;188:118-27.
14. Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J 2001;20:197-206.
15. Waugh MA. Balanitis. Dermatol Clin 1998;16:757-62.
16. Vazquez JA. Invasive oesophageal candidiasis: current and developing treatment options. Drugs 2003;63:971-89.
17. Levine J, Dykoski RK, Janoff EN. Candida-associated diarrhea: a syndrome in search of credibility. Clin Infect Dis 1995;21:881-6.
18. Salvaggio MR, Pappas PG. Current concepts In the management of fungal peritonitis. Curr Infect Dis Rep 2003;5: 120-4.
19. Bibashi E, Memmos D, Kokolina E, Tsakiris D, Sofianou D, Papadimitriou M. Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases. Clin Infect Dis 2003;36:927-31.
20. Isenmann R, Schwarz M, Rau B, Trautmann M, Schober W, Beger HG. Characteristics of Infection with Candida species in patients with necrotizing pancreatitis. World J Surg 2002;26:372-6.
21. Diebel LN, Raafat AM, Dulchavsky SA, Brown WJ. Gallbladder and biliary tract candidiasis. Surgery 1996;120:760-5.
22. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multlcenter surveillance study of funguria In hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000;30:14-8.
23. Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992;11:99-109.
24. Oude Lashof AM, Donnelly JP, Meis JF, Van der Meer JW, Kullberg BJ. Duration of antifungal treatment and development of delayed complications In patients with candidaemia. Eur J Clin Microbiol Infect Dis 2003;22:43-8.
25. Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. A prospective observational study of candidemia: epidemiology, therapy, and Influences on mortality In hospitalized adult and pediatrie patients. Clin Infect Dis 2003;37:634-43.
26. Bisbe J, Miro JM, Latorre X, Moreno A, Mallolas J, Gatell JM, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis 1992;15:910-23.
27. Rodriguez-Adrian LJ, King RT, Tamayo-Derat LG, Miller JW, Garcia CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal Infections: frequency, natural history, and etiology. Medicine 2003;82:187-202.
28. Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000;13: 662-85.
29. Sanchez-Portocarrero J, Perez-Cecilia E, Corral O, Romero-Vivas J, Picazo JJ. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis 2000;37:169-79.
30. Geers TA, Gordon SM. Clinical significance of Candida species Isolated from cerebrospinal fluid following neuro-surgery. Clin Infect Dis 1999;28:1139-47.
31. Abgueguen P, Gouello JP, Pichard E, Chabasse D, Donal E, Alquier P. Candida endocarditis: retrospective study in 12 patients. Rev Med Interne 2002;23:30-40.
32. Lefort A, Gantier J-C, Lortholary O. Endocardites fongiques. Réanimation 2004;13:197-204.
33. Rabinovici R, Szewczyk D, Ovadia P, Greenspan JR, Sivalingam JJ. Candida pericarditis: clinical profile and treatment. Ann Thorac Surg 1997;63:1200-4.
34. Franklin WG, Simon AB, Sodeman TM. Candida myocarditis without valvulitis. Am J Cardiol 1976;38:924-8.
35. Clancy CJ, Nguyen MH, Morris AJ. Candidal mediastinitis: an emerging clinical entity. Clin Infect Dis 1997;25:608-13.
36. Miller DJ, Mejicano GC. Vertebral osteomyelitis due to Candida species: case report and literature review. Clin Infect Dis 2001;33:523-30.
37. el-Ebiary M, Torres A, Fabregas N, de la Bellacasa JP, Gonzalez J, Ramirez J, et al. Significance of the Isolation of Candida species from respiratory samples In critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 1997; 156(2Pt1):583-90.
38. Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP. Primary Candida pneumonia. Experience at a large cancer center and review of the literature. Medicine 1993;72: 137-42.
39. Kauffman CA, Bradley SF, Ross SC, Weber DR. Hepatosplenic candidiasis: successful treatment with fluconazole. Am J Med 1991;91:137-41.
40. Noyola DE, Fernandez M, Moylett EH, Baker CJ. Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 2001;32:1018-23.
41. Cassone M, Serra P, Mondello F, Girolamo A, Scafetti S, Pistella E, et al. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol 2003;41:5340-3.
42. Samonis G, Anatoliotaki M, Apostolakou H, Maraki S, Mavroudis D, Georgoulias V. Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature. Infection 2001;29:173-6.
43. Kessler AT, Kourtis AP, Simon N. Peripheral thromboembolism associated with Malassezia furfur sepsis. Pediatr Infect Dis J 2002;21:356-7.
44. Bretagne S. Diagnostic des infections fongiques profondes. Recherche d'antigènes et d'anticorps, détection d'ADN. Définitions et avancées récentes. In: Lortholary EO, editor. Les mycoses. Paris: ESME; 2003. p. 13-31.
45. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002;15:465-84.
46. Bretagne S. Molecular diagnostics in clinical parasitology and mycology: limits of the current polymerase chain reaction (PCR) assays and interest of the real-time PCR assays. Clin Microbiol Infect 2003;9:505-11.
47. Chen SC, Halliday CL, Meyer W. A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med Mycol 2002;40:333-57.
48. Mirrett S, Reller LB, Petti CA, Woods CW, Vazirani B, Sivadas R, et al. Controlled clinical comparison of BacT/ALERT standard aerobic medium with BACTEC standard aerobic medium for culturing blood. J Clin Microbiol 2003;41:2391-4.
49. Fricker-Hidalgo H, Orenga S, Lebeau B, Pelloux H, Brenier-Pinchart MP, Ambroise-Thomas P, et al. Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species. J Clin Microbiol 2001;39:1647-9.
50. Yucesoy M, Marol S. Performance of CHROMAGAR candida and BIGGY agar for identification of yeast species. Ann Clin Microbiol Antimicrob 2003;2:8.
51. Botterel F, Desterke C, Costa C, Bretagne S. Analysis of microsatellite markers of Candida albicans used for rapid typing. J Clin Microbiol 2001;39:4076-81.
52. Bougnoux ME, Morand S, d'Enfert C. Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans. J Clin Microbiol 2002;40:1290-7.
53. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:662-78.
54. Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002;40:3551-7.
55. Sendid B, Poirot JL, Tabouret M, Bonnin A, Caillot D, Camus D, et al. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol 2002;51:433-42.
56. Costa C, Costa JM, Desterke C, Botterel F, Cordonnier C, Bretagne S. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microblol 2002;40: 2224-7.
57. Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004;351: 876-83.
58. Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003;63:1059-66.
59. Sobel JD, Kauffman CA, McKinsey D, Zervos M, Vazquez JA, Karchmer AW, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000;30:19-24.
60. Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clin Infect Dis 2001;32:1602-7.
61. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-89.
62. Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J. The role of Candida sp. isolated from bronchoscopic samples in non neutropenic patients. Chest 1998;114: 146-9.
63. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, et al. Fluconazole prophylaxis prevents intraabdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066-72.
64. Bohme A, Ruhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, et al. Treatment of fungal infections in hematology and oncology-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82(suppl2):S133-40.
65. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003;3: 230-40.
66. Eggimann P, Garbino J, Pittet D. Management of Candida species Infections In critically ill patients. Lancet Infect Dis 2003;3:772-85.
67. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis 2002;34:591-9.
68. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species Infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003;3:685-702.
69. Conférences SPILR, SPILF, SRLF. Prise en charge des candidoses et aspergilloses invasives de l'adulte. Paris. 13 mai 2004.
70. Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, et al. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in non neutropenic subjects. Clin Infect Dis 2003;36:1221-8.
71. Martinez-Vazquez C, Fernandez-Ulloa J, Bordon J, Sopena B, de la Fuente J, Ocampo A, et al. Candida albicans endophthalmltis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis 1998;27:1130-3.
72. Bow EJ, Laverdiere M, Lussier N, Rotstein C, Cheang MS, loannou S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta-analysis of randomized-controlled clinical trials. Cancer 2002;94:3230-46.
73. Sandven P, Giercksky KE. Yeast colonization in surgical patients with intra-abdominal perforations. Fur J Clin Microbiol Infect Dis 2001;20:475-81.
74. Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients. A randomized, doubleblind, placebo-controlled trial. Ann Intern Med 1999;131: 729-37.
75. EORTC, International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989;86:668-72.
76. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72: 101-11.
77. Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, et al. Voriconazole compared with Uposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346:225-34.
78. Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004;351: 1391-402.